New treatment found for insulin resistance

Guffrey, Laurie
July 1995
Clinical Diabetes;Jul/Aug95, Vol. 13 Issue 4, p69
Academic Journal
Reports on a study at the University of California, San Diego which found that insulin resistance in obese patients with or without diabetes can be effectively treated with the drug troglitazone.


Related Articles

  • Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients. Hillenbrand, Andreas; Knippschild, Uwe; Weiss, Manfred; Schrezenmeier, Hubert; Henne-Bruns, Doris; Huber-Lang, Markus; Wolf, Anna M. // BMC Surgery;2010, Vol. 10, p26 

    Background: Hyperglycemia and insulin resistance frequently occur in critically ill and in morbidly obese (MO) patients. Both conditions are associated with altered serum levels of cytokines and adipokines. In addition, obesity related alterations in adipokine expression contribute to insulin...

  • New drugs target diabetes control, insulin resistance. Klink, Barbara // Drug Topics;11/4/96, Vol. 140 Issue 21, p19 

    Presents information on diabetic medications pimagedine and troglitazone. Ability of pimagedine to impede formation of advanced glycosylation end products (AGEs); Troglitazone as treatment of insulin resistance; Effect of troglitazone on liver and skeletal muscle.

  • The Effect of Acute Exercise on Serum Vaspin Level and Its Relation to Insulin Sensitivity in Overweight Elderly Men. Bashiri, Jabbar; Rahbaran, Adel; Gholami, Farhad; Ahmadizad, Sajad; Nikoukheslat, Saeid; Moradi, Akram // Zahedan Journal of Research in Medical Sciences;Aug2014, Vol. 16 Issue 8, p16 

    Background: Vaspin is a new discovered adipocytokine which is a member of serine protease inhibitor family secreted from adipose tissue and might play a role in insulin sensitivity. The purpose of this study was to investigate the effect of acute exercise on serum vaspin levels and its relation...

  • Evaluation of Body Mass Index (BMI) Percentile cut-off Levels with Reference to Insulin Resistance: A Comparative Study on South Indian Obese and Non-Obese Adolescents. GANDHE, MAHENDRA BHAURAOJI; LENIN, M.; SRINIVASAN, A. R. // Journal of Clinical & Diagnostic Research;Aug2013, Vol. 7 Issue 8, p1579 

    Objectives: To investigate the relationship of Body Mass Index (BMI) percentile cut off with Homeostasis Model Assessment-Insulin Resistance (HOMA-IR), a surrogate marker for insulin resistance in obese, overweight and non-obese adolescents. Study Design: A cross-sectional analysis of 120...

  • Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome. Odrowąż-Sypniewska, G. // Advances in Medical Sciences (De Gruyter Open);2007, Vol. 52, p246 

    The metabolic syndrome refers to the clustering of upper body obesity, atherogenic dyslipidemia, insulin resistance and elevated blood pressure. Both, obesity and metabolic syndrome, have the potential to influence on the incidence and severity of cardiovascular disease with serious implications...

  • Paradoxical Associations of Insulin Resistance With Total and Cardiovascular Mortality in Humans. Ki-Su Kim; Yu-Mi Lee; In-Kyu Lee; Dae-Jung Kim; Jacobs Jr, David R.; Duk-Hee Lee // Journals of Gerontology Series A: Biological Sciences & Medical ;Jul2015, Vol. 70 Issue 7, p847 

    Background. Insulin resistance is linked to many human chronic diseases. Paradoxically, however, impaired insulin signaling contributes to longevity in various organisms and is suggested as an adaptive mechanism against external stressors, including obesity. We formulated a novel hypothesis that...

  • First of a new class of diabetes drugs targets insulin resistance.  // Modern Medicine;Mar97, Vol. 65 Issue 3, p38 

    Reports that the US Food and Drug Administration (FDA) has cleared the insulin-resistance reducer called troglitazone (Rezulin) for marketing. Drug indications; Dosage and administration; Results of clinical trials on troglitazone.

  • Ask the doctor. Phelps, Kerryn // Australian Women's Weekly;Jun2004, Vol. 74 Issue 6, p158 

    Answers several questions related to the health of women in Australia. Re-implantation of ovarian tissue in a woman who had undergone chemotherapy; Risk factors for insulin resistance in women; Recommendations for treating colds.

  • Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. Gatta-Cherifi, B; Matias, I; Vallée, M; Tabarin, A; Marsicano, G; Piazza, P V; Cota, D // International Journal of Obesity;Jun2012, Vol. 36 Issue 6, p880 

    Background:The endocannabinoid system is a potential pharmacotherapy target for obesity. However, the role of this system in human food intake regulation is currently unknown.Methods:To test whether circulating endocannabinoids might functionally respond to food intake and verify whether these...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics